Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter 2007 Financial Results
Date:3/4/2008

IRVINE, Calif., March 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release fourth quarter 2007 financial results on March 6, 2008, after the U.S. markets close. ISTA will host a conference call, with a simultaneous webcast, to discuss these results and provide a commercial and pipeline update at 5:00 p.m. Eastern Time on March 6.

To access the live conference call, U.S. and Canadian participants may dial 866-831-6270; international participants may dial 617-213-8858. The access code for the live call is 99457780. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 57762235. This conference call also will be webcast live and archived on ISTA's website until April 7, 2008, at http://www.istavision.com.

About ISTA

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
2. Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
5. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
6. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
7. Lotus Pharmaceuticals Raises $5 Million in Private Placement
8. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
10. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
11. RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ings at Stevens Institute of Technology will prese..., journalist and founder, Bloggingheads.tv, Wednes...o Center for Technology Management, Room 122. The ...., In his new book "The Evolution of God," the b...his popular works on evolutionary psychology, pres...
(Date:11/23/2009)...elf-reported by American surgeons are strongly rel...s appear today in the online edition of Annals of...aborators from Johns Hopkins and the American Coll... nearly 9 percent of U.S. surgeons responding said... to being surveyed. Over 70 percent attributed the...
(Date:11/23/2009)... Society of America (IDSA) has asked for a commitm... Union to further the Society,s mission to achieve...next 10 years, known as the 10 x ,20 Initiative. ... antimicrobial resistance as one of the three grea...nion report confirms there are just 15 antibacteri...
(Date:11/23/2009)... more screen time than those in center-based care,...Day News) --Young children of working parents may ... reports have found, especially kids in home-based...chers from Seattle Children,s Hospital and the Uni...to find out how much television viewing was availa...
(Date:11/23/2009)...announce its participation in the 2009 CR report c...ssible amongst all major CR vendors. iCRco is the ...n sales, service and technology fields and scored ...nality. iCRco is very pleased to have been rated w...arch firm in medical imaging, KLAS. , ...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3
...ges dedicated to disseminating breast cancer infor...titutions in the Houston have determined that whil...e, one in 20 breast cancer Web pages featured inac...Published in the March 15 issue of Cancer and onli...
...CVD) today announced that it will present at the U...ry 11th at 1:30 pm ET. Investors may access a,live...e.com . In order to register,and download any nece...nsive drug development services companies,with ann...
... voluntary recall by Chattem, Inc., announced it i.... Chattem is recalling these products based on,con...rns as well as skin,irritation resulting from cons... 1. Icy Hot Heat Therapy Air Activated Heat- Back ...
...ine,s Day gift than the,"gift of life?", WASHINGT...e have held more than 1,900 community donor drives...with local blood center partners,as part of Saturn...o and the South Texas Blood and Tissue,Center. The...
...anie Tubbs Jones announced that six new constructi...d for the Louis Stokes Cleveland VA Medical,Center...g for the new,construction was made possible by a ...I am extremely pleased that we were able to secure...
...ogy Holdings, Inc. (Nasdaq: NHWK ), a leading pro...ross the United States, announced today that,the t...ngs conference call,has been changed to February 1...ourth quarter and full-year 2007 conference call w...
Other Medicine News:Health News:Review of online breast cancer information encourages healthy skepticism for consumers 2Health News:Giant Food Alerts Customers to Voluntary Recall of Chattem Icy Hot Heat Therapy Products 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 3Health News:NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call 2
(Date:11/23/2009)..., THEWOODLANDS,Texas,Nov.23/PRNewswire-FirstC...,announcedtodaythattop-linedatafromitsPhase2clinic...rritablebowelsyndrome(IBS)willbepresentedatGASTRO2...dasignificantimprovementinIBSsymptoms,willbepresen...ntofclinicaldevelopment,onNovember25,2009at2:30pml...
(Date:11/23/2009)..., EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRese...M): Feraheme report,thesecondinamulti-phasesyndi...snewIVironproduct,Feraheme,throughthefirstsixmonth...quantitativeinformationfrom50uniqueNephrologistsan...ssesstrialanduseofFeraheme,obstaclestouse,reasonst...
(Date:11/23/2009)..., FORTWORTH,Texas,Nov.23/PRNewswire-FirstCall...ard:WNDM)arapidlygrowingproviderofspecialtymedical...esultsandhasprovidedacomprehensivemanagementbusine...lendaryear. ,, Q32009salesincreased33.5%to$102...ityasoftheQ32009increasedto$3,327,892vs.Q32008shar...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Medicsight Announces Global Agreement With Alma IT Systems 50043 1Medicsight Announces Global Agreement With Alma IT Systems 50043 2Medicsight Announces Global Agreement With Alma IT Systems 50043 3Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 1Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 2Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 3Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 4Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 5BIO Ventures for Global Health Announces Management Changes 12785 1BIO Ventures for Global Health Announces Management Changes 12785 2
...icals,Inc. (Nasdaq: JAZZ ) today announced compl... pivotal clinical trials of JZP-6 (sodium oxybate)...ion of enrollment in this second trial is a meanin...a. We expect to report top-line results,from this... Executive Officer. , The JZP-6 Phase III clin...
...he Swedish,fragment-based drug discovery company, ...ment with GE Healthcare (Chalfont St. Giles, UK), ...n analysis tools, and Uppsala,University (Sweden...proach to,fragment-based drug discovery and GE Hea...xpertise from Uppsala University . , (Logo: ...
Other Medicine Technology:Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 3Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University 2
Thalia Eyewear Collection
...wear, a dainty, feminine collection of ophthalmic ... The Norville Group. Utterly chic, slightly playfu... bring metals, acetates, supras and rimless models..., beta-titanium and buffalo horn. The luxurious m...
...is something that almost all retailers must addres... with VALUE - not just in price but also in qualit...is among the LEADING eyewear collections for manag...lection of contemporary and classic styling combin...
Lacoste Sun Collection
Medicine Products: